DNA甲基化驱动的转录表达特征作为肝癌预后预测标志物的价值
|
骆红波, 曹鹏博, 周钢桥
|
Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma
|
Luo Hongbo, Cao Pengbo, Zhou Gangqiao
|
|
表2 10个最优基因的Cox比例风险回归分析结果、LASSO回归系数和基因组变异频率
|
Table 2 The results of Cox proportional hazard model analysis, LASSO regression coefficients and genetic alteration of the 10 optimal genes
|
|
基因 | HR (95% CI) | P值 | LASSO系数 | 基因组变异频率(%) | CDCA8 | 2.21 (1.54~3.01) | <0.0001 | 0.1194 | 0.0 | PRC1 | 1.85 (1.29~2.54) | 0.0005 | 0.08869 | 0.3 | MAPT | 1.72 (1.21~2.46) | 0.0021 | 0.2597 | 1.7 | SFN | 1.72 (1.21~2.45) | 0.0021 | 0.001652 | 0.3 | STC2 | 1.73 (1.22~2.43) | 0.0021 | 0.03600 | 0.8 | MYO18B | 1.69 (1.19~2.37) | 0.0031 | 0.1932 | 4.0 | PBK | 1.67 (1.17~2.35) | 0.0036 | 0.06524 | 6.0 | MAEL | 1.55 (1.09~2.17) | 0.013 | -0.1766 | 10.0 | TTC39A | 1.55 (1.09~2.17) | 0.013 | -0.01347 | 1.4 | LPL | 1.55 (1.10~2.18) | 0.014 | 0.003126 | 7.0 |
|
|
|